| IMS Announces 17 Countries Now Rank as High-Growth ‘Pharmerging’ Markets; Forecast to Contribute Nearly Half of Industry Growth by 2013 |
| More | |
|
NORWALK, Conn.--(BUSINESS WIRE)--IMS Health today announced that 17 high-growth pharmaceutical markets are now ranked as “pharmerging,” up from seven currently, reflecting an unprecedented shift of industry growth to the world’s emerging economies. A new IMS study, “Pharmerging Shake-Up: New Imperatives in a Redefined World,” predicts that these 17 countries will in aggregate expand by US$90 billion during 2009-13 and contribute 48 percent of annual market growth in
|
In Connecticut, business is a CONNTACT sport.
We're looking for business people that want to share thei